New Study Co-Authored by Dr. Rubright Explores Optimal Intrathecal Morphine Dosing for Cesarean Deliveries

We’re excited to share that Dr. Elizabeth Rubright, faculty in the Department of Anesthesiology, is a co-author on a newly published study in International Journal of Obstetric Anesthesia titled: “Intrathecal morphine 100 µg versus 150 µg for post-cesarean delivery analgesia: a retrospective cohort study (2020–2022).”

This retrospective cohort study evaluates the effectiveness of two commonly used intrathecal morphine doses—100 µg and 150 µg—for pain control following cesarean deliveries. The research provides important insights into how varying doses may influence postoperative outcomes and pain management in obstetric anesthesia.

The publication reflects our department’s continued commitment to advancing evidence-based care in obstetric anesthesiology and improving maternal outcomes.